Posttraumatic stress disorder in aware patients from the B-aware trial.
BACKGROUND
The long-term consequences of an awareness episode vary. Some patients do not have any long-term disability, whereas others develop psychological problems that may be severe and persistent. In this study, we compared the incidence of posttraumatic stress disorder (PTSD) in patients with and without confirmed awareness who were randomized in the B-Aware Trial.


METHODS
We used a matched cohort design, aiming to follow up the 13 patients with confirmed awareness. Each surviving awareness patient was matched with 4 controls for age, sex, surgery type, date of surgery, and hospital. A face-to-face interview was conducted with each awareness patient and matched controls using the Clinician Administered Posttraumatic Stress Disorder Scale.


RESULTS
Data collection for this study occurred between June 2006 and March 2007, with a median follow-up time of 5.3 yr (range, 4.3-5.7 yr). Six of the 13 confirmed awareness patients had died. Five of the 7 confirmed awareness patients (71%) and 3 of the 25 controls (12%) fulfilled the criteria for PTSD at the time of the interview (adjusted odds ratio = 13.3 [95% confidence interval: 1.4-650]; P = 0.02). The median onset time of symptoms was 14 days (range, 7-243 days) after surgery, and the median duration of symptoms was 4.7 yr (range, 4.4-5.6 yr).


CONCLUSIONS
PTSD was common and persistent in the confirmed awareness patients of the B-Aware Trial. Strategies to prevent awareness in patients under general anesthesia are justified.
Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia. kate.leslie@mh.org.au
Kate
K
Leslie
Matthew T V
MT
Chan
Paul S
PS
Myles
Andrew
A
Forbes
Timothy J
TJ
McCulloch
D000368:Aged; D000369:Aged, 80 and over; D000768:Anesthesia, General / Q000523:psychology*; D001364:Awareness / Q000187:drug effects*; D056805:Consciousness Monitors; D004569:Electroencephalography / Q000295:instrumentation; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage* / Q000009:adverse effects; D015994:Incidence; D008297:Male; D008875:Middle Aged; D016343:Monitoring, Intraoperative / Q000295:instrumentation / Q000379:methods; D011446:Prospective Studies; D012815:Signal Processing, Computer-Assisted; D013313:Stress Disorders, Post-Traumatic / Q000453:epidemiology / Q000209:etiology* / Q000523:psychology; D011795:Surveys and Questionnaires; D013997:Time Factors
D006993:Hypnotics and Sedatives